All In Biotech

Drug Trial Radar · NCT00817414

A Study to Evaluate the Effects of LCI699 on Cortisol in Participants With Hypertension

A Phase II, Randomized, Double-blind, Placebo Controlled, Multi-center Study to Evaluate the Effects of LCI699 on Cortisol in Patients With Hypertension

Last checked: Nov 19, 2026Latest source record: Jun 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

63

Actual

Start

Jan 14, 2009

Primary completion

Aug 12, 2009

Study completion Aug 12, 2009

Sponsor

Lead sponsor
NovartisNovartis (NVS)
Sponsor type
Industry
Collaborators
Great Lakes Drug Development, Inc.; Integrium
First posted
Jan 6, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study determined the maximum dose of LCI6999 with respect to effect on the ACTH-stimulated cortisol response in participants with hypertension.

Conditions

  • Hypertension

Interventions

  • LCI699-matching placeboDrug

    LCI699-matching placebo oral capsules

  • LCI699Drug

    LCI699 oral capsules

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum Tolerated Dose (MTD) of LCI699 With Respect to Effect on the Adrenocorticotropic Hormone (ACTH)-Stimulated Cortisol Response Following ACTH Stimulation in Hypertensive ParticipantsTime frame: Up to Week 6

Locations

11 sites in 2 countries. Site status is shown where the registry gives one.

  • Impact Clinical Trials

    Beverly Hills, California

  • Associated Pharmaceutical Research Center, Inc

    Buena Park, California

  • Innovative Clinical Research, Inc

    Harbor City, California

  • Long Beach Center for Clinical Research

    Long Beach, California

  • Metro Clinical Research

    Littleton, Colorado

  • Clinical Study Center of Asheville, LLC

    Asheville, North Carolina

  • Northstate Clinical Research

    Lenoir, North Carolina

  • Tipton Medical & Diagnostic Center

    Tipton, Pennsylvania

  • Punzi Medical Center

    Carrollton, Texas

  • dgd Research, Inc

    San Antonio, Texas

  • Encode Clinic

    Reykjavik, SA, Iceland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.